Alumis draws Outperform at Oppenheimer
Oppenheimer downgrades Apple to Perform
U.S. filmmaker Joshua Oppenheimer, now based in Denmark, worries his "home country is perhaps becoming a dictatorship." "It ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
The card collecting industry has exploded in recent years to such an extent that industry leader Topps is now producing a Robert Oppenheimer card that's ...
In a report released yesterday, Kristen Owen from Oppenheimer maintained a Buy rating on Cf Industries Holdings (CF – Research Report), with a ...
U.K. home entertainment hits record $6.4 billion as 'Wonka' leads formats, with streaming and 'Dune 2,' 'Oppenheimer' driving ...
Shares of Apple have surged roughly 40% over the past nine months, but one analyst issued a cautious warning that it’s time to tap the brakes ahead of the company’s earnings report set for Thursday.
Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...
Amid the financial shock waves being sent by the release of DeepSeek's open source artificial intelligence R1 model, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback